Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2291)
All Articles published online
|
Dec 21, 2009 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lanas A, Esplugues JV, Zapardiel J, Sobreviela E. Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications. World J Gastroenterol 2009; 15(47): 5953-5959 [PMID: 20014459 DOI: 10.3748/wjg.15.5953] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i47/5953.htm |
| Number | Citing Articles |
| 1 |
Angel Lanas, Ma Josep Plazas, Eva Gimeno, Marta Muñoz-Tudurí. Gastroprotection in NSAID and low-dose aspirin users: A cross-sectional study in primary care. Gastroenterología y Hepatología 2012; 35(1): 1 doi: 10.1016/j.gastrohep.2011.10.004
|
| 2 |
Carlos Sostres, Ángel Lanas. Prescripción apropiada, adherencia y seguridad de los antiinflamatorios no esteroideos. Medicina Clínica 2016; 146(6): 267 doi: 10.1016/j.medcli.2015.09.022
|
| 3 |
R. Casado‐Arroyo, J. M. Scheiman, M. Polo‐Tomas, S. D. Saini, A. Del Rio, E. Guastello, A. Lanas. Underutilization of gastroprotection for at‐risk patients undergoing percutaneous coronary intervention: Spain compared with the United States. Alimentary Pharmacology & Therapeutics 2010; 32(5): 689 doi: 10.1111/j.1365-2036.2010.04393.x
|
| 4 |
Carlos Sostres, Ángel Lanas. Appropriate prescription, adherence and safety of non-steroidal anti-inflammatory drugs. Medicina Clínica (English Edition) 2016; 146(6): 267 doi: 10.1016/j.medcle.2016.05.006
|
| 5 |
Angel Lanas, Maria Muñoz, Maria Caballero Correa, Pedro Martínez Jiménez. Análisis de las diferencias entre indicación y prescripción de gastroprotección en pacientes con factores de riesgo tratados con antiinflamatorios no esteroideos: estudio GAP. Gastroenterología y Hepatología 2010; 33(2): 80 doi: 10.1016/j.gastrohep.2009.09.009
|
| 6 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2010; 19(7) doi: 10.1002/pds.1852
|
| 7 |
Biswa Mohan Padhy, Hemant Singh Bhadauria, Yogendra Kumar Gupta. Attitude and Knowledge of Indian Emergency Care Residents towards Use of Proton Pump Inhibitors. International Scholarly Research Notices 2014; 2014: 1 doi: 10.1155/2014/968430
|
| 8 |
Carlos Martín de Argila de Prados, Lara Aguilera Castro, Enrique Rodríguez de Santiago. PPIs: Between overuse and underprescription when really necessary. Revista Española de Enfermedades Digestivas 2015; 107 doi: 10.17235/reed.2015.4022/2015
|
| 9 |
A. Lanas, L. A. García‐Rodríguez, M. Polo‐Tomás, M. Ponce, E. Quintero, M. A. Perez‐Aisa, J. P. Gisbert, L. Bujanda, M. Castro, M. Muñoz, M. D. Del‐Pino, S. Garcia, X. Calvet. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Alimentary Pharmacology & Therapeutics 2011; 33(5): 585 doi: 10.1111/j.1365-2036.2010.04563.x
|
| 10 |
Pacharaporn Phueanpinit, Juraporn Pongwecharak, Janet Krska, Narumol Jarernsiripornkul. Evaluation of community pharmacists’ roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand. Primary Health Care Research & Development 2018; 19(6): 598 doi: 10.1017/S1463423618000142
|
| 11 |
Jacob E. Kurlander, Danielle Helminski, Michael Lanham, Jennifer L. Henstock, Kelley M. Kidwell, Sarah L. Krein, Sameer D. Saini, Caroline R. Richardson, Raymond De Vries, Kenneth Resnicow, Allison Laboon Ruff, David M. Wallace, Elizabeth K. Jones, Linda K. Perry, Jacqueline Parsons, Nghi Ha, Tina Alexandris-Souphis, Dale Dedrick, Elizabeth Aldridge, Geoffrey D. Barnes. Development of a multicomponent implementation strategy to reduce upper gastrointestinal bleeding risk in patients using warfarin and antiplatelet therapy, and protocol for a pragmatic multilevel randomized factorial pilot implementation trial. Implementation Science Communications 2022; 3(1) doi: 10.1186/s43058-022-00256-8
|